Literature DB >> 35601991

On testing for homogeneity with zero-inflated models through the lens of model misspecification.

Wei-Wen Hsu1, Nadeesha R Mawella2, David Todem3.   

Abstract

In many applications of two-component mixture models such as the popular zero-inflated model for discrete-valued data, it is customary for the data analyst to evaluate the inherent heterogeneity in view of observed data. To this end, the score test, acclaimed for its simplicity, is routinely performed. It has long been recognized that this test may behave erratically under model misspecification, but the implications of this behavior remain poorly understood for popular two-component mixture models. For the special case of zero-inflated count models, we use data simulations and theoretical arguments to evaluate this behavior and discuss its implications in settings where the working model is restrictive with regard to the true data generating mechanism. We enrich this discussion with an analysis of count data in HIV research, where a one-component model is shown to fit the data reasonably well despite apparent extra zeros. These results suggest that a rejection of homogeneity does not imply that the underlying mixture model is appropriate. Rather, such a rejection simply implies that the mixture model should be carefully interpreted in the light of potential model misspecifications, and further evaluated against other competing models.

Entities:  

Keywords:  count data; cure rate survival model; score test; size of test

Year:  2021        PMID: 35601991      PMCID: PMC9122237          DOI: 10.1111/insr.12462

Source DB:  PubMed          Journal:  Int Stat Rev        ISSN: 0306-7734            Impact factor:   1.946


  17 in total

1.  Long-term survivor mixture model with random effects: application to a multi-centre clinical trial of carcinoma.

Authors:  K K Yau; A S Ng
Journal:  Stat Med       Date:  2001-06-15       Impact factor: 2.373

2.  Cure fraction estimation from the mixture cure models for grouped survival data.

Authors:  Binbing Yu; Ram C Tiwari; Kathleen A Cronin; Eric J Feuer
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

3.  Two-component mixture cure rate model with spline estimated nonparametric components.

Authors:  Lu Wang; Pang Du; Hua Liang
Journal:  Biometrics       Date:  2011-12-14       Impact factor: 2.571

4.  On Lagrange Multiplier Tests in Multidimensional Item Response Theory: Information Matrices and Model Misspecification.

Authors:  Carl F Falk; Scott Monroe
Journal:  Educ Psychol Meas       Date:  2017-07-06       Impact factor: 2.821

5.  A sup-score test for the cure fraction in mixture models for long-term survivors.

Authors:  Wei-Wen Hsu; David Todem; KyungMann Kim
Journal:  Biometrics       Date:  2016-04-14       Impact factor: 2.571

6.  On the efficiency of score tests for homogeneity in two-component parametric models for discrete data.

Authors:  David Todem; Wei-Wen Hsu; KyungMann Kim
Journal:  Biometrics       Date:  2012-02-20       Impact factor: 2.571

7.  Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial.

Authors:  Mei-Chen Hu; Martina Pavlicova; Edward V Nunes
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

8.  CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men.

Authors:  J Burcham; M Marmor; N Dubin; B Tindall; D A Cooper; G Berry; R Penny
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

9.  CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.

Authors:  Cécile Goujard; Mojgan Bonarek; Laurence Meyer; Fabrice Bonnet; Marie-Laure Chaix; Christiane Deveau; Martine Sinet; Julie Galimand; Jean-François Delfraissy; Alain Venet; Christine Rouzioux; Philippe Morlat
Journal:  Clin Infect Dis       Date:  2006-01-24       Impact factor: 9.079

10.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

Authors:  H Masur; F P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; W Travis; A F Suffredini; L Deyton; J A Kovacs; J Falloon
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.